Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements Sep 20, 2017
Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test Sep 11, 2017
Interpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Sep 7, 2017
Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017 Aug 31, 2017
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price Aug 31, 2017
Interpace Diagnostics Group Reports Second Quarter 2017 Financial Results, Business Progress and Recent Accomplishments Aug 10, 2017
